Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2007
10/09/2007CA2235811C Hybrid matrix implants and explants
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
10/09/2007CA2099503C Synthetic alpha-l-iduronidase and genetic sequences encoding same
10/04/2007WO2007112051A2 Polypyrimidine-tract binding protein (ptb) as a biomarker and target for the diagnosis and treatment of cancer
10/04/2007WO2007112001A2 Compositions and methods for treating myocardial infarction
10/04/2007WO2007111421A1 A method for treating tumor using irradiated tumor cell expressing human hepatitis b surface antigen and a pharmaceutical composition comprising the tumor cell
10/04/2007WO2007111350A1 Agent for inhibition of angiogenesis or mesenchymal-type or amoeboid-type invasion of cancer cell
10/04/2007WO2007111275A1 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof
10/04/2007WO2007047573A3 Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods
10/04/2007WO2007045389A3 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma
10/04/2007WO2007044362A3 Allele-specific rna interference
10/04/2007WO2007030619A3 Pharmaceutical compositions for delivery of ribonucleic acid to a cell
10/04/2007WO2007026246A3 Synapse-specific proteins in glomeruli
10/04/2007WO2007025231A3 Methods using snail transcriptional repressor
10/04/2007WO2007015170A3 Synapse-specific proteins in glomeruli
10/04/2007WO2006124847A3 Anti-tumoral compositions and methods
10/04/2007WO2006036502A8 Improved expression of factor ix in gene therapy vectors
10/04/2007US20070232798 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom
10/04/2007US20070232558 Methods and compositions for treating prostate cancer using dna vaccines directed to cancer testis antigen
10/04/2007US20070232557 Methods and compositions for inhibiting the function of polynucleotide sequences
10/04/2007US20070232556 Methods and compositions for the treatment of neurological diseases and disorders
10/04/2007US20070232553 MODULATION OF INNATE IMMUNITY RECEPTORS' SIGNALING BY microRNAs miR-146a AND miR-146b
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070232538 Uses of polypeptides
10/04/2007US20070232520 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
10/04/2007US20070232519 Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascualr disorders
10/04/2007US20070231862 Peptide scaffolds for transfer of molecules into eukaryotic cells
10/04/2007US20070231412 Deactivating viruse by adsorption, binding
10/04/2007US20070231392 CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY
10/04/2007US20070231341 Cat dander allergen treatments
10/04/2007US20070231335 Compositions and methods for treating Gram positive bacterial infection in a mammalian subject
10/04/2007US20070231331 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta ); drug screening
10/04/2007US20070231330 Method for the improvement of neuronal regeneration
10/04/2007US20070231310 Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
10/04/2007US20070231309 Cell populations which co-express CD49c and CD90
10/04/2007US20070231308 Pharmacokinetics; chemical stability; gene therapy
10/04/2007US20070231304 Prognostic factors for anti-hyperproliferative disease gene therapy
10/04/2007US20070231303 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
10/04/2007US20070231270 Biopolymer and Gene Complex
10/04/2007US20070231263 Human G protein-coupled receptor and modulators thereof for the treatment of hyperglycemia and related disorders
10/04/2007US20070231262 Hepatitis C virus variants
10/03/2007EP1839669A1 Novel angiogensis inhibitor
10/03/2007EP1839667A2 Cell-based gene therapy for the pulmonary system
10/03/2007EP1839664A1 Agent for regulating bone formation
10/03/2007EP1838353A2 Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
10/03/2007EP1838351A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/03/2007EP1838347A1 Pharmaceutical compositions for treating diseases associated with nf-kappab activity
10/03/2007EP1623034A4 Mechanisms of myoblast transfer in treating heart failure
10/03/2007EP1501548A4 Chemically activated carboxypolysaccharides and uses
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1351968B1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/03/2007EP1351744B1 Use of specific erbb4 antagonists for treating stenosis
10/03/2007EP1337285B1 Implants with a phosphazene-containing coating
10/03/2007EP1227840B1 Adjuvanted genetic vaccines
10/03/2007EP1187916B1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
10/03/2007EP1135482B1 Cancer cell vaccine
10/03/2007EP1100942B1 Herpes virus vectors for dendritic cells
10/03/2007EP1037974B1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
10/03/2007EP0874900B1 Improved nucleic acids encoding a chimeric glycosyltransferase
10/03/2007CN101048502A Modified human hepatitis c virus genomic rna having autonomous replicative competence
10/03/2007CN101048181A Bacteria delivering system
10/03/2007CN101045037A Cationic elaioplast and its adenovirus composition, its preparing method and use
10/03/2007CN100340670C Application of Nano carbon tubes in biology
10/03/2007CN100340668C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
10/03/2007CN100340665C Human p51 genes and gene products thereof
10/03/2007CN100340289C Method to enhance an immune response of nucleic acid vaccination
10/03/2007CN100340220C Method for planting esoderma/endothelial cell on inner surface of artificial blood vessel
10/02/2007US7276643 Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents
10/02/2007US7276594 Nucleic acid-containing complex
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276580 Neurotrophic factors
10/02/2007US7276490 Administering to the cancer cell a pharmaceutical formulation of a nucleic acid encoding and expressing a prostacyclin synthase as an active ingredient and a nucleic acid encoding and expressing a cyclooxygenase-2
10/02/2007US7276488 Vector system
10/02/2007US7276481 Method and composition for treatment of skeletal dysplasias
10/02/2007US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof
10/02/2007US7276356 Linking a transcriptional control element that binds a DNA-directed RNA polymerase to a DNA sequence that encodes an RNA molecule having a binding site specific for an RNA-directed RNA polymerase of an influenza virus linked to the reverse complement of an mRNA coding sequence of an influenza virus
10/02/2007US7276353 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
10/02/2007US7276352 Induction of β cell differentiation in human cells by stimulation of the GLP-1 receptor
10/02/2007US7276333 Viral infection inhibitor targeting integrase N-terminal domain
10/02/2007US7276283 Spacer chains covalently bound to the polymer surface, biomolecules covalently bound to the spacer chains, surface treated diamond-like carbon film, bioactive surfaces made from surface-bound biomolecules, bioassays, biosensors
10/02/2007US7276242 Fowl pox viral construct composed of a first nucleic acid molecule encoding HIV Gag and/or Pol or derivatives and a second nucleic acid molecule encoding gamma-interferon and derivatives, effective in inducing, enhancing or otherwise stimulating an immune response to Gag and/or Pol.
10/02/2007US7276240 Antibodies to novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
10/02/2007US7276234 Introducing a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes, and expressing the foreign DNA in the thymus during differentiation and maturation of the fetal immature T lymphocyte to reconstitute the immune system
10/02/2007US7276233 Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy
09/2007
09/27/2007WO2007109350A2 Modulation of innate immunity receptors' signaling by micrornas mir-146a and mir-146b
09/27/2007WO2007109180A2 Stabilized, sterilized collagen scaffolds with active adjuncts attached
09/27/2007WO2007109107A2 Atf4 as a therapeutic target in alzheimers disease and other neurological disorders
09/27/2007WO2007109097A2 RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
09/27/2007WO2007108992A2 Augmentation of endothelial thromboresistance
09/27/2007WO2007108990A2 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
09/27/2007WO2007108621A1 Sirna for inhibiting nf-kb/rela expression
09/27/2007WO2007108557A1 Control of intracellular target molecule by ip3 receptor-binding protein
09/27/2007WO2007108434A1 Expression construct for digesting aggregating protein and method of inhibiting the aggregation of aggregating protein
09/27/2007WO2007107380A2 Use of pol iii promoters for controlled expression of therapeutic proteins
09/27/2007WO2007028065A3 Chimeric oligomeric compounds for modulation of splicing
09/27/2007WO2006078278A3 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
09/27/2007WO2005092033A3 Preventing arrhythmias associated with cell transplantation
09/27/2007US20070225244 Compositions comprising genome segments and methods of using the same
09/27/2007US20070225243 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
09/27/2007US20070225242 Method and composition for treating and preventing tumor metastasis in vivo